⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Mindray and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Mindray
↗Shenzhen, China
Mindray is a leading global developer, manufacturer, and supplier of medical devices and solutions. Founded in 1991, the company provides a comprehensive portfolio of products across three primary business segments: Patient Monitoring & Life Support, In-Vitro Diagnostics, and Medical Imaging Systems.
Headquartered in Shenzhen, China, Mindray operates a vast global network with R&D centers and sales offices worldwide. The company is committed to making healthcare more accessible by transforming advanced technologies into clinical innovations, serving hospitals and healthcare providers in over 190 countries and regions.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Patient Monitoring, In-Vitro Diagnostics, Medical Imaging
SIZE & FINANCIALS
Employees:10000+
Revenue:$4B-$5B
Founded:1991
Ownership:public
Status:operating
STOCK
Exchange:Shenzhen Stock Exchange
Ticker:300760.SZ
Market Cap:$25B+
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:Medical Imaging, Patient Monitoring, In-Vitro Diagnostics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Mindray DS USA, Inc., Mindray Medical India Pvt. Ltd., Mindray Medical Poland
Key Partnerships:Major U.S. hospital buying groups, Global healthcare provider networks
COMPETITION
Position:Leader
Competitors:Philips, GE Healthcare, Siemens Healthineers, Masimo, Dräger
LEADERSHIP
Key Executives:
Hang Xu - Founder
Scientific Founders:Hang Xu
LINKS
Website:mindray.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Mindray. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.